Pierre Fabre
New ways to care 

Find the 2025 annual report (2024 figures) online. We have placed this year’s annual report under the sign of a “new energy” resulting in :  International growth Therapeutic innovations Medical leadership Financial solidity Collective commitment  

Toulouse, June 20, 2025 - Pierre Fabre Laboratories announces the appointment of Audrey Ricard Campion as Head of Research and Development for its Dermo-Cosmetics & Personal Care business. Reporting to Frédéric Ennabli, CEO of Pierre Fabre Dermo-Cosmetics, she will join the Executive Committee and will be responsible for defining and implementing the company’s innovation strategy. An engineering graduate in physics and chemistry, Audrey Ricard Campion has acquired in-depth expertise in the science of skin over the course of her career. Her work, characterized by the encapsulation and vectorization of active ingredients and pigments, as well as the use of adhesive polymers, has given rise to numerous patents, particularly in the fields of photoprotection and facial skincare. Audrey will now be putting her experience to work for Pierre Fabre Laboratories' Dermo-Cosmetics & Personal Care portfolio, which includes major international brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer and Elgydium. Audrey Ricard Campion will be based at the Pierre Fabre Innovation Center, on the Oncopole campus in Toulouse. She will head up an organization of 420 employees based mainly in Toulouse, as well as in the innovation centers in Shanghai, specializing in Asian skin types, and Rio de Janeiro, specializing in skin types found in South America.  She will be able to draw on multidisciplinary expertise, including biology, clinical pharmacology, biotechnology and formulation, to support priority fields of research such as sun protection, acne treatment, atopy, skin repair and alopecia.

SECAUCUS, NJ (June 18, 2025): Pierre Fabre Laboratories, a global healthcare company originated from France, announces the inauguration of its new US office located on 500 Plaza Drive, in Secaucus, NJ which will host its dermo-cosmetics and medical care subsidiaries. Pierre Fabre is the world’s second-largest dermo-cosmetics manufacturer and a global player in oncology, cell & gene therapy, rare disease and dermatology. This strategic move in the US marks a pivotal moment in the company’s growth strategy, underscoring its strong commitment to advancing in the US in both dermo-cosmetics and medical care. Pierre Fabre Laboratories introduced global dermo-cosmetics brands Avène, Klorane and René Furterer to the US market in the 1990’s. With an ever-growing desire for French dermo-cosmetics, the US dermo-cosmetics business has become a top priority. Building upon their success in oncology and dermatology in Europe and Asia, the company has recently expanded its medical care investments in the US through the creation of a dedicated pharmaceutics unit, Pierre Fabre Pharmaceuticals (PFP). This subsidiary is focused on continuing to deliver breakthrough therapies in rare diseases and oncology to American patient populations with high unmet needs and limited treatment options.